Free tool
FAERS Monitor: Zestril
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 019777 or its brand name (Zestril, Lisinopril). Reports on generic versions are filed under their own applications.
Reports
307,269
Serious
186,997
61% of reports
Hospitalization
98,349
Death reported
25,491
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fatigue20,139
- nausea18,701
- drug ineffective17,858
- diarrhoea17,531
- dyspnoea14,122
- pain13,788
- dizziness13,716
- headache13,187
- off label use11,262
- vomiting11,193
- asthenia11,051
- arthralgia9,780
- acute kidney injury9,626
- fall9,216
- chronic kidney disease9,132
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 3,531 |
| 2005 | 4,429 |
| 2006 | 4,749 |
| 2007 | 4,668 |
| 2008 | 5,695 |
| 2009 | 7,749 |
| 2010 | 10,965 |
| 2011 | 11,262 |
| 2012 | 13,038 |
| 2013 | 12,466 |
| 2014 | 17,956 |
| 2015 | 22,223 |
| 2016 | 22,908 |
| 2017 | 21,645 |
| 2018 | 23,498 |
| 2019 | 22,728 |
| 2020 | 18,102 |
| 2021 | 15,726 |
| 2022 | 15,254 |
| 2023 | 13,279 |
| 2024 | 12,698 |
| 2025 | 13,641 |
| 2026 | 9,056 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,746,890 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| chronic kidney diseaseSignal | 9,132 | 9.2 | 9.0 | 59,039 |
| acute kidney injurySignal | 9,626 | 4.5 | 4.4 | 24,970 |
| astheniaSignal | 11,051 | 2.0 | 2.0 | 5,810 |
| fall | 9,216 | 1.9 | 1.9 | 4,019 |
| dizziness | 13,716 | 1.9 | 1.9 | 5,896 |
| diarrhoea | 17,531 | 1.9 | 1.9 | 7,285 |
| fatigue | 20,139 | 1.8 | 1.8 | 7,118 |
| dyspnoea | 14,122 | 1.7 | 1.7 | 4,318 |
| vomiting | 11,193 | 1.6 | 1.6 | 2,825 |
| nausea | 18,701 | 1.6 | 1.6 | 4,647 |
| arthralgia | 9,780 | 1.6 | 1.6 | 2,340 |
| pain | 13,788 | 1.5 | 1.5 | 2,699 |
| headache | 13,187 | 1.4 | 1.4 | 1,852 |
| drug ineffective | 17,858 | 0.9 | 0.9 | 109 |
| off label use | 11,262 | 0.9 | 0.9 | 194 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.